Guiding treatment selection with immunotherapy compared to targeted therapy agents in patients with metastatic kidney cancer

Expert Review of Precision Medicine and Drug Development · Published 2022-01-02 · DOI 10.1080/23808993.2022.2156786

Authors being retrieved — see the publisher record. https://doi.org/10.1080/23808993.2022.2156786

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2022

Related articles